Secondary navigation

Off-patent Drugs Bill 2015-16

Type of Bill:
Private Members' Bill (Ballot Bill)
Sponsor:
Nick Thomas-Symonds

Progress of the Bill

Bill started in the House of Commons

  1. House of Commons
    1. 1st reading
    2. 2nd reading
    3. Committee stage
    4. Report stage
    5. 3rd reading
  2. House of Lords
    1. 1st reading
    2. 2nd reading
    3. Committee stage
    4. Report stage
    5. 3rd reading
  3. Consideration of Amendments
  4. Royal Assent

Latest Bill

House Bill Date
Commons Bill 14 2015-16, as introduced | PDF version, 91KB 05.11.2015

Latest news on the Off-patent Drugs Bill 2015-16

This Bill has been withdrawn and will not progress any further.

The Bill was presented to Parliament through the ballot procedure on 24 June 2015. This is known as the first reading and there was no debate on the Bill at this stage.

The debate on second reading on Friday 6 November 2015 was adjourned. 

Summary of the Off-patent Drugs Bill 2015-16

A Bill to require the Secretary of State to seek licences for off-patent drugs in new indications; to require the National Institute for Health and Care Excellence to conduct technology appraisals for off-patent drugs in new indications; and for connected purposes.

Stay up to date

Keep up to date with the progress of Bills going through Parliament. Sign up for email alerts or use our RSS feeds.

Related information

Guide to the passage of a Bill

Find out what happens at each stage of a Public Bill’s journey through Parliament with the Passage of a Bill guide.

When does a Bill become law?

Explanation of what happens after Bills have been passed, and when laws may change.